Nuvectis Pharma (NVCT) Insider Trading & Ownership → Does this make you sick? (From Allegiance Gold) (Ad) Free NVCT Stock Alerts $6.63 -0.14 (-2.07%) (As of 03:28 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Nuvectis Pharma (NASDAQ:NVCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage38.85%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$3.10 MNumber OfInsiders Selling(Last 12 Months)0 Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NVCT Insider Buying and Selling by Quarter Ad Awesomely, LLCAutomatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video Nuvectis Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/10/2024Enrique PoradosuInsiderBuy500$6.29$3,145.00 5/10/2024Ron BentsurCEOBuy2,000$6.40$12,800.00 3/18/2024Ron BentsurCEOBuy5,000$10.29$51,450.00 10/9/2023Ron BentsurCEOBuy830$11.19$9,287.70 10/6/2023Ron BentsurCEOBuy250$11.27$2,817.50 10/4/2023Ron BentsurCEOBuy1,820$10.95$19,929.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/15/2023Ron BentsurCEOBuy235$14.34$3,369.90 8/11/2023Ron BentsurCEOBuy180$14.66$2,638.80 8/8/2023Ron BentsurCEOBuy120$14.83$1,779.60 7/31/2023Marlio Charles MosseriMajor ShareholderBuy860$13.88$11,936.80 7/28/2023Marlio Charles MosseriMajor ShareholderBuy2,584$13.91$35,943.44 7/26/2023Marlio Charles MosseriMajor ShareholderBuy10,000$13.97$139,700.00 7/21/2023Ron BentsurCEOBuy225$14.85$3,341.25 7/20/2023Marlio Charles MosseriMajor ShareholderBuy5,394$14.40$77,673.60 7/19/2023Ron BentsurCEOBuy200$14.33$2,866.00 7/18/2023Marlio Charles MosseriMajor ShareholderBuy9,149$14.84$135,771.16 7/14/2023Ron BentsurCEOBuy150$15.03$2,254.50 7/11/2023Marlio Charles MosseriMajor ShareholderBuy10,000$15.36$153,600.00 7/7/2023Marlio Charles MosseriMajor ShareholderBuy8,948$15.19$135,920.12 7/6/2023Ron BentsurCEOBuy320$14.88$4,761.60 7/5/2023Marlio Charles MosseriMajor ShareholderBuy1,176$15.52$18,251.52 6/26/2023Marlio Charles MosseriMajor ShareholderBuy16,760$16.46$275,869.60 6/26/2023Ron BentsurCEOBuy750$16.50$12,375.00 6/23/2023Marlio Charles MosseriMajor ShareholderBuy73,175$17.43$1,275,440.25 6/21/2023Marlio Charles MosseriMajor ShareholderBuy6,091$17.71$107,871.61 6/21/2023Ron BentsurCEOBuy500$17.88$8,940.00 6/15/2023Marlio Charles MosseriMajor ShareholderBuy32,124$17.71$568,916.04 6/7/2023Ron BentsurCEOBuy230$17.41$4,004.30 5/31/2023Ron BentsurCEOBuy330$17.28$5,702.40 5/24/2023Ron BentsurCEOBuy200$17.49$3,498.00 5/16/2023Ron BentsurCEOBuy320$17.02$5,446.40 (Data available from 1/1/2013 forward) NVCT Insider Trading Activity - Frequently Asked Questions Who is on Nuvectis Pharma's Insider Roster? The list of insiders at Nuvectis Pharma includes Enrique Poradosu, Kenneth Hoberman, Marlio Charles Mosseri, Ron Bentsur, and Shay Shemesh. Learn more on insiders at NVCT. What percentage of Nuvectis Pharma stock is owned by insiders? 38.85% of Nuvectis Pharma stock is owned by insiders. Learn more on NVCT's insider holdings. Which Nuvectis Pharma insiders have been buying company stock? The following insiders have purchased NVCT shares in the last 24 months: Enrique Poradosu ($8,920.00), Marlio Charles Mosseri ($2,936,894.14), Ron Bentsur ($604,167.43), and Shay Shemesh ($25,722.90). How much insider buying is happening at Nuvectis Pharma? Insiders have purchased a total of 240,466 NVCT shares in the last 24 months for a total of $3,575,704.47 bought. More Insider Trading Tools from MarketBeat Related Companies: AMLX Insider Selling KPTI Insider Selling FGEN Insider Selling SYRS Insider Selling SGMT Insider Selling VTGN Insider Selling PDSB Insider Selling DMAC Insider Selling RPTX Insider Selling ABEO Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:NVCT) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport Societyis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldHow to Make 100X on the AI BoomInvestorPlaceTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsAmazon's betting big on this unknown AI companyManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.